Liminatus Pharma, Inc. (LIMN)

1.44 -0.40 (-21.74%) USD  |  NASDAQ  |  Feb 09, 16:00
1.45 +0.01 (+0.69%) After-Hours: 18:12
More

Liminatus Pharma Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for LIMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
CDT Equity, Inc. --
LENZ Therapeutics, Inc. Upgrade
Oruka Therapeutics, Inc. --
Maze Therapeutics, Inc. --
MapLight Therapeutics, Inc. --